Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 1997

View Archived Issues

Company Profile: Transkaryotic Therapies

Notice of allowance issued for DepoTech's drug delivery patent

Bayer seeks FDA approval for metrifonate for Alzheimer's disease

KeraVision Ring evaluated in extended phase III trial

RPR redirects development of PDE IV inhibitor

New cytokine production inhibitors revealed by SS Pharm.

Japanese researchers develop new animal model of obesity

First launch for Detrusitol

Collagenase treatment for Dupuytren's disease enters phase II

Torii reveals antidiabetic thiazolidinediones

New histamine antagonists described for dermatological indications

New antitumor compound QM16-A described in patent literature

Spotlight on selective estrogen receptor modulators

AcuTect submitted for EU approval

Prokinetic effects described for DQ-2511, an antiulcer agent from Daiichi

CGP-49823 compares favorably to diazepam in rat model of anxiety

Topical FK-506 for skin allograft rejection

Novel agent for insulin resistance, S-15261, evaluated in rat model

Titan and Novartis collaborate on antipsychotic drug

Pharmacological effects and pharmacokinetics of Org-21465 in humans

Pharmacopeia/Texas Biotechnology drug discovery collaboration

Proceedings from symposium on estrogen and dementia

Update on pagoclone

InKine (formerly Panax) completes acquisitions, raises funds for CBP-1011 development

Imutec licenses novel anticancer compounds from Ion

RIGScan EMEA review delayed

Amylin, SIDDCO join forces for metabolic drug discovery

Allergan files registration statement for new company

Floxin recommended for FDA approval

Accolate now available in Canada

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...